| Title： | Guidelines for Vaccination in Kidney Transplant Candidates and Recipients in China |
| Edition： | Original |
| Classification： | Standard guideline |
| Field： | Prevention |
| Countries and regions： | China |
| Guidelines users： | Medical workers in the field of kidney transplantation in China |
| Evidence classification method： | This guide uses the Oxford Center for Evidence-Based Medicine: Levels of Evidence (2009) to grade the supporting evidence for the recommendations. The specific description of the evidence level is as follows: A 1a systematic review of randomized controlled studies; 1b randomized controlled studies with small confidence intervals; 1c any evidence that shows "all or none effects"; B 2a systematic review of cohort studies; 2b single cohort study; 2c patient-centered outcomes research; 3a systematic review of case-control studies; 3b single case-control study; C 4 case series reports, low-quality cohort studies and low-quality case-control studies; D 5 expert opinion. |
| Development unit： | Branch of Organ Transplantation, Chinese Medical Association |
| Registration time: | 2024-04-22 |
| Registration number： | PREPARE-2024CN569 |
| Purpose of the guideline: | To provide theoretical basis and reference for medical workers in the field of kidney transplantation in China in terms of vaccination in kidney transplant candidates and recipients, so as to better guide the kidney transplant candidates and recipients in vaccination, thereby reducing the risk of post-operative infection, and improving the survival. |
